AstraZeneca manufactures Breztri Aerosphere [1].
Who else makes respiratory inhalers like Breztri?
Other companies also produce inhalers for respiratory conditions. For example, GSK manufactures Advair Diskus, an inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD) [2].
What is Breztri Aerosphere used for?
Breztri Aerosphere is a combination inhaler used for the maintenance treatment of patients with COPD [1]. It contains three active ingredients: budesonide, glycopyrrolate, and formoterol fumarate [1]. These ingredients work together to help control symptoms of COPD, such as coughing and shortness of breath, and reduce the frequency of exacerbations [1].
When did Breztri Aerosphere receive approval?
Breztri Aerosphere was approved by the U.S. Food and Drug Administration (FDA) in July 2020 [1].
What are the main ingredients in Breztri Aerosphere?
Breztri Aerosphere contains budesonide, a corticosteroid that reduces inflammation; glycopyrrolate, an anticholinergic that helps relax the airways; and formoterol fumarate, a long-acting beta2-agonist that helps open the airways [1].
How does Breztri Aerosphere work?
The three active ingredients in Breztri Aerosphere work in different ways to improve breathing in COPD patients. Budesonide reduces inflammation in the lungs. Glycopyrrolate blocks the action of acetylcholine, a substance that causes airway muscles to contract, thus helping to relax and widen the airways. Formoterol fumarate stimulates beta2-adrenergic receptors in the lungs, which also leads to relaxation of airway muscles and helps keep the airways open [1].
What is the difference between Breztri Aerosphere and other COPD inhalers?
Breztri Aerosphere is a triple-combination inhaler, meaning it contains three different medications in one device: an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta2-agonist (LABA) [1]. Many other COPD inhalers contain only one or two of these types of medications. This triple therapy aims to provide comprehensive symptom control and reduce exacerbations for some COPD patients [1].
What are the potential side effects of Breztri Aerosphere?
Common side effects of Breztri Aerosphere can include nasopharyngitis (cold-like symptoms), pneumonia, bronchitis, oral candidiasis (thrush), and hoarseness [1]. Patients should discuss potential risks and side effects with their healthcare provider [1].
Can Breztri Aerosphere be used for asthma?
Breztri Aerosphere is indicated for the maintenance treatment of COPD. It is not approved for the treatment of asthma [1].
What are the patent and exclusivity details for Breztri Aerosphere?
Information regarding the specific patents and exclusivity periods for Breztri Aerosphere can be found on patent tracking websites like DrugPatentWatch.com [3]. These resources detail patent numbers, expiry dates, and any patent challenges that may affect market exclusivity.
---
Sources:
1. https://www.breztri.com/
2. https://www.gsksupporters.com/advair/
3. https://drugpatentwatch.com/